Sign in

CIK 0001576885 · <br>Emerging growth company

Acumen Pharmaceuticals, Inc.

Sign in to watch
Ticker
ABOS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
364108129
Phone
617-344-4190
Business address
1210-1220 WASHINGTON STREET, SUITE 210, NEWTON, MA, 02465
  1. 8-K Event Agreement ended · Exit or restructuring costs
  2. 8-K Event Regulation FD disclosure · Other events
  3. 8-K Event Results of operations · Regulation FD disclosure
  4. 8-K Event Regulation FD disclosure
  5. 8-K Event Results of operations · Regulation FD disclosure
  6. 8-K Event Regulation FD disclosure · Other events
  7. 8-K Event Shareholder vote results
  8. 8-K Event Results of operations · Regulation FD disclosure
  9. 8-K Event Results of operations · Regulation FD disclosure
  10. 8-K Event Material agreement · Unregistered share sale · Regulation FD disclosure
  11. 8-K Event Regulation FD disclosure
  12. 8-K Event Results of operations · Regulation FD disclosure
  13. 8-K Event Executive or director change · Regulation FD disclosure
  14. 8-K Event Results of operations · Regulation FD disclosure
  15. 8-K Event Material agreement · Regulation FD disclosure
  16. 8-K Event Shareholder vote results
  17. 8-K Event Results of operations · Regulation FD disclosure
  18. 8-K Event Results of operations · Regulation FD disclosure
  19. 8-K Event Results of operations · Regulation FD disclosure
  20. 8-K Event Results of operations · Regulation FD disclosure

Page 1 of 3 · 57 filings